Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID‐19 and pulmonary fibrosis: A potential role for lung epithelial cells and fibroblasts
Alison E. John, Chitra Joseph, Gisli Jenkins, et al.
Immunological Reviews (2021) Vol. 302, Iss. 1, pp. 228-240
Open Access | Times Cited: 165

Showing 1-25 of 165 citing articles:

Proposed subtypes of post‐COVID‐19 syndrome (or long‐COVID) and their respective potential therapies
Shin Jie Yong, Shiliang Liu
Reviews in Medical Virology (2021) Vol. 32, Iss. 4
Open Access | Times Cited: 134
Cellular mechanotransduction in health and diseases: from molecular mechanism to therapeutic targets
Xingpeng Di, Xiaoshuai Gao, Liao Peng, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 134
SARS-CoV-2 infection produces chronic pulmonary epithelial and immune cell dysfunction with fibrosis in mice
Kenneth H. Dinnon, Sarah R. Leist, Kenichi Okuda, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 664
Open Access | Times Cited: 92
The costs and benefits of senotherapeutics for human health
Marco Raffaele, Manlio Vinciguerra
The Lancet Healthy Longevity (2022) Vol. 3, Iss. 1, pp. e67-e77
Open Access | Times Cited: 89
Lung function and radiological findings 1 year after COVID-19: a prospective follow-up
Julia Tarrasó, Belén Safont, Juan Antonio Carbonell-Asíns, et al.
Respiratory Research (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 69
Post-COVID-19 Pulmonary Fibrosis: Facts—Challenges and Futures: A Narrative Review
Sy Duong‐Quy, Thu Vo-Pham-Minh, Quynh Tran-Xuan, et al.
Pulmonary Therapy (2023) Vol. 9, Iss. 3, pp. 295-307
Open Access | Times Cited: 46
One-year follow-up of chest CT findings in patients after SARS-CoV-2 infection
Yanfei Chen, Cheng Ding, Ling Yu, et al.
BMC Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 68
Pulmonary fibrosis from molecular mechanisms to therapeutic interventions: lessons from post-COVID-19 patients
Chiara Giacomelli, Rebecca Piccarducci, Laura Marchetti, et al.
Biochemical Pharmacology (2021) Vol. 193, pp. 114812-114812
Open Access | Times Cited: 62
Hesperidin inhibits lung fibroblast senescence via IL-6/STAT3 signaling pathway to suppress pulmonary fibrosis
Di Han, Haiying Gong, Yun Wei, et al.
Phytomedicine (2023) Vol. 112, pp. 154680-154680
Closed Access | Times Cited: 32
Possible cancer-causing capacity of COVID-19: Is SARS-CoV-2 an oncogenic agent?
Kasra Jahankhani, Fatemeh Ahangari, Ian M. Adcock, et al.
Biochimie (2023) Vol. 213, pp. 130-138
Open Access | Times Cited: 31
Post-COVID-19 pulmonary fibrosis: An ongoing concern
Nuha Alrajhi
Annals of Thoracic Medicine (2023) Vol. 18, Iss. 4, pp. 173-181
Open Access | Times Cited: 31
Systematic review of overlapping microRNA patterns in COVID-19 and idiopathic pulmonary fibrosis
Julien Guiot, Monique Henket, Claire Remacle, et al.
Respiratory Research (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 24
Long-term Radiological and Pulmonary Function Abnormalities at 3-year post COVID-19 Hospitalization: A Longitudinal Cohort Study
Xiaoyu Han, Lu Chen, Li-Yan Guo, et al.
European Respiratory Journal (2024) Vol. 64, Iss. 1, pp. 2301612-2301612
Open Access | Times Cited: 10
The Role of Cytokines and Molecular Pathways in Lung Fibrosis Following SARS-CoV-2 Infection: A Physiopathologic (Re)view
Mihai Lazăr, Mihai Săndulescu, Ecaterina Constanța Barbu, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 639-639
Open Access | Times Cited: 7
Genetic overlap between idiopathic pulmonary fibrosis and COVID-19
Richard J. Allen, Beatriz Guillén‐Guío, Emma Croot, et al.
European Respiratory Journal (2022) Vol. 60, Iss. 1, pp. 2103132-2103132
Open Access | Times Cited: 34
The Interaction Between Pulmonary Fibrosis and COVID-19 and the Application of Related Anti-Fibrotic Drugs
Hao Shen, Nu Zhang, Yuqing Liu, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 32
Lung fibrosis: Post-COVID-19 complications and evidences
Rishabh Hirawat, Namrata G. Jain, Mohd Aslam Saifi, et al.
International Immunopharmacology (2022) Vol. 116, pp. 109418-109418
Open Access | Times Cited: 32
Persistent Lung Injury and Prothrombotic State in Long COVID
Mengqi Xiang, Haijiao Jing, Chengyue Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 30
An Inhaled Galectin-3 Inhibitor in COVID-19 Pneumonitis: A Phase Ib/IIa Randomized Controlled Clinical Trial (DEFINE)
Erin Gaughan, Tom Quinn, Andrew C. Mills, et al.
American Journal of Respiratory and Critical Care Medicine (2022) Vol. 207, Iss. 2, pp. 138-149
Open Access | Times Cited: 27
Post-acute sequelae of COVID-19 in older persons: multi-organ complications and mortality
Eric Yuk Fai Wan, Ran Zhang, Sukriti Mathur, et al.
Journal of Travel Medicine (2023) Vol. 30, Iss. 5
Closed Access | Times Cited: 20
Oxidative Stress and Lung Fibrosis: Towards an Adverse Outcome Pathway
Patrudu Makena, Tatiana Kikalova, G. L. Prasad, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12490-12490
Open Access | Times Cited: 20
LRRC15 mediates an accessory interaction with the SARS-CoV-2 spike protein
Jarrod Shilts, Thomas W.M. Crozier, Ana Teixeira-Silva, et al.
PLoS Biology (2023) Vol. 21, Iss. 2, pp. e3001959-e3001959
Open Access | Times Cited: 16
Down-regulation of KLF2 in lung fibroblasts is linked with COVID-19 immunofibrosis and restored by combined inhibition of NETs, JAK-1/2 and IL-6 signaling
Akrivi Chrysanthopoulou, Christina Antoniadou, Anastasia‐Maria Natsi, et al.
Clinical Immunology (2023) Vol. 247, pp. 109240-109240
Open Access | Times Cited: 15
Are biological rhythms a predictive factor in the need for oxygen therapy in COVID-19 patients?
Mohammad Esmaeelzadeh, Elahe Allahyari
Biological Rhythm Research (2025), pp. 1-13
Closed Access
Page 1 - Next Page

Scroll to top